Psyence Biomedical Ltd. (PBMWW)Toronto, Canada | NasdaqCM
0.02 USD
0.00
(-5.859%) ⇩
(July 13, 2026, 2:52 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:49 a.m. EDT
The immediate outlook is severely bearish, driven by a statistically significant prediction of nearly a 30% drop over the next 45 days, which aligns with the stock trading at its 52-week low. Fundamentally, the business is in distress with negative returns on assets and equity, burning through cash, and showing no signs of profitability. There is no dividend income to offset these risks, and the lack of price history prevents any assessment of long-term resilience. This is a clear sell signal for both short-term traders and long-term investors. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.000000 |
| AutoETS | 0.001704 |
| MSTL | 0.001815 |
| AutoTheta | 0.007986 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 91% |
| H-stat | 0.00 |
| Ljung-Box p | nan |
| Jarque-Bera p | nan |
| Excess Kurtosis | nan |
| Attribute | Value |
|---|---|
| Beta | 1.68 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://psyencebiomed.com |
| Attribute | Value |
|---|---|
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite 1300 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.681 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 7.389 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0241 |
| Current Ratio | 14.619 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0243 |
| Day Low | 0.0241 |
| Display Name | Psyence Biomedical |
| Ebitda | -6,232,245 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0243 |
| Fifty Two Week High Change | -0.00019999966 |
| Fifty Two Week High Change Percent | -0.008230438 |
| Fifty Two Week Low | 0.0241 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0241 - 0.0243 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 2,607,742 |
| Free Cashflow | -4,955,898 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Long Business Summary | Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -6,936,421 |
| Open | 0.024 |
| Operating Cashflow | -8,143,007 |
| Operating Margins | 0.0 |
| Phone | 416-477-1708 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 0.0256 |
| Price Hint | 4 |
| Price To Book | 0.003261605 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.122 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0014999993 |
| Regular Market Change Percent | -5.8593726 |
| Regular Market Day High | 0.0243 |
| Regular Market Day Low | 0.0241 |
| Regular Market Day Range | 0.0241 - 0.0243 |
| Regular Market Open | 0.024 |
| Regular Market Previous Close | 0.0256 |
| Regular Market Price | 0.0241 |
| Regular Market Time | 1,783,968,766 |
| Regular Market Volume | 2,500 |
| Return On Assets | -0.31333 |
| Return On Equity | -0.58619 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Short Name | Psyence Biomedical Ltd. Warrant |
| Source Interval | 15 |
| State | ON |
| Symbol | PBMWW |
| Total Cash | 7,444,763 |
| Total Cash Per Share | 1.952 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 2,500 |
| Website | https://psyencebiomed.com |
| Zip | M5H 2K1 |